These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35669451)

  • 1. The truncated form of flagellin (tFlic) provides the 2dCap subunit vaccine with better immunogenicity and protective effects in mice.
    Lu Y; Liu Z; Li Y; Deng Z; Fang W; He F
    Anim Dis; 2022; 2(1):11. PubMed ID: 35669451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCV cap proteins fused with calreticulin expressed into polymers in Escherichia coli with high immunogenicity in mice.
    Liu C; Liu Y; Feng H; Zhao B; Chen Y; Huang H; Wang P; Deng R; Zhang G
    BMC Vet Res; 2020 Aug; 16(1):313. PubMed ID: 32854700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice.
    Liu X; Liu Y; Zhang Y; Zhang F; Du E
    BMC Vet Res; 2020 Feb; 16(1):45. PubMed ID: 32028949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo.
    Lu Y; Liu ZH; Li YX; Xu HL; Fang WH; He F
    Int J Nanomedicine; 2022; 17():1593-1608. PubMed ID: 35411142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
    Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
    Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
    Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
    Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.
    Masuda A; Lee JM; Miyata T; Sato T; Hayashi S; Hino M; Morokuma D; Karasaki N; Mon H; Kusakabe T
    J Gen Virol; 2018 Jul; 99(7):917-926. PubMed ID: 29851377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both recombinant
    Zhang Y; Wu Y; Peng C; Li Z; Wang G; Wang H; Yu L; Wang F
    Heliyon; 2023 Dec; 9(12):e22941. PubMed ID: 38058449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
    Wu PC; Chen TY; Chi JN; Chien MS; Huang C
    J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
    Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli.
    Yin S; Sun S; Yang S; Shang Y; Cai X; Liu X
    Virol J; 2010 Jul; 7():166. PubMed ID: 20646322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated Diphtheria Toxin DT390 Enhances the Humoral Immunogenicity of Porcine Circovirus Type 2 Capsid Antigen in Mice.
    Chang XX; Fan K; Meng W; Guo J; Zhao D; Yin W; Li H; Wang Z
    Viral Immunol; 2021 Sep; 34(7):448-456. PubMed ID: 33902339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis.
    Li PC; Qiao XW; Zheng QS; Hou JB
    Vaccine; 2016 Jan; 34(5):696-702. PubMed ID: 26372858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles.
    Liu ZH; Deng ZF; Lu Y; Fang WH; He F
    J Nanobiotechnology; 2022 Nov; 20(1):493. PubMed ID: 36424615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2.
    Li Y; Wang Y; Cheng J; Zhou X; Lu H; Zhang X; Xia X; Sun H
    Virol J; 2020 Jun; 17(1):72. PubMed ID: 32517704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets.
    Zhu S; Zhang C; Wang J; Wei L; Quan R; Yang J; Yan X; Li Z; She R; Hu F; Liu J
    PLoS One; 2016; 11(2):e0147432. PubMed ID: 26848967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preparation of porcine circovirus type 2 (PCV2) virus-like particles using a recombinant pseudorabies virus and its application to vaccine development.
    Chi JN; Wu CY; Chien MS; Wu PC; Wu CM; Huang C
    J Biotechnol; 2014 Jul; 181():12-9. PubMed ID: 24739460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacing the decoy epitope of PCV2 capsid protein with epitopes of GP3 and/or GP5 of PRRSV enhances the immunogenicity of bivalent vaccines in mice.
    Jung BK; Kim HR; Jang H; Chang KS
    J Virol Methods; 2020 Oct; 284():113928. PubMed ID: 32650038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
    Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
    Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation.
    Zhan Y; Yu W; Cai X; Lei X; Lei H; Wang A; Sun Y; Wang N; Deng Z; Yang Y
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.